GRAMD1C, also known as GRAM domain-containing protein 1C, is a protein encoded in humans by the GRAMD1C gene. It is a member of the GRAMD protein family, characterized by the presence of a GRAM domain – a protein-binding domain that is often involved in membrane-associated processes. The GRAM domain typically enables the protein to interact with phospholipids in the membrane, suggesting a role for GRAMD1C in cellular signaling or trafficking that involves lipid membrane dynamics.
The precise function of GRAMD1C is not fully elucidated, but proteins in this family are generally implicated in important biological functions, including membrane trafficking, signal transduction, and metabolism. The GRAM domain itself is named for its presence in proteins such as glucosyltransferases, Rab-like GTPase activators, and myotubularins. This domain's role in lipid binding indicates that GRAMD1C might participate in the detection or decoding of lipid signaling or in the regulation of membrane curvature, which is crucial for processes like endocytosis and vesicular trafficking.Beyond the GRAM domain, GRAMD1C may contain other functional motifs that contribute to its cellular role. However, without more specific knowledge about its interacting partners and regulatory mechanisms, the full spectrum of its activities in the cell remains to be discovered.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which can influence lipid metabolism and potentially affect GRAMD1C activity. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
As a PPAR-gamma agonist, Pioglitazone regulates lipid metabolism and glucose homeostasis, which may indirectly affect GRAMD1C. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
Similar to Pioglitazone, Rosiglitazone, another PPAR-gamma agonist, could indirectly modulate GRAMD1C activity through lipid metabolic pathways. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $80.00 $175.00 | 28 | |
This PPAR-delta agonist is known to affect lipid metabolism, potentially impacting GRAMD1C function. | ||||||
GW3965 | 405911-09-3 | sc-490151 sc-490151A sc-490151B | 10 mg 50 mg 1 g | $260.00 $872.00 $1637.00 | ||
Liver X Receptor (LXR) agonists like GW3965 regulate lipid homeostasis, possibly influencing GRAMD1C. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
As a PPAR-alpha agonist, Fenofibrate alters lipid metabolism, which could indirectly affect GRAMD1C activity. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $32.00 | ||
Similar to Fenofibrate, Clofibrate is a PPAR-alpha agonist that may influence GRAMD1C through lipid metabolic pathways. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
This HMG-CoA reductase inhibitor impacts cholesterol synthesis, potentially influencing GRAMD1C activity. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
Similar to Simvastatin, Atorvastatin affects cholesterol metabolism and may indirectly affect GRAMD1C. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $94.00 $236.00 | 12 | |
Ezetimibe inhibits cholesterol absorption, which could impact lipid metabolism and GRAMD1C function. | ||||||